These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12017208)

  • 1. Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromes.
    Michalis LK; Tambaki AP; Katsouras CS; Goudevenos JA; Kolettis T; Adamides K; Tselepis AD; Sideris DA
    Curr Med Res Opin; 2002; 18(2):108-12. PubMed ID: 12017208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy.
    Tselepis AD; Goudevenos JA; Tambaki AP; Michalis L; Stroumbis CS; Tsoukatos DC; Elisaf M; Sideris DA
    Cardiovasc Res; 1999 Jul; 43(1):183-91. PubMed ID: 10536703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet response to the aggregatory effect of platelet activating factor (PAF) ex vivo in patients with acute myocardial infarction.
    Tselepis AD; Tsoukatos D; Droudes C; Donas A; Evangelou A
    Eur J Clin Invest; 1991 Oct; 21(5):490-6. PubMed ID: 1752288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregability to platelet activating factor at rest and after exercise in patients with coronary artery disease.
    Goudevenos J; Tselepis AD; Tsoukatos D; Grekas G; Kritikakos J; Sideris D
    Eur Heart J; 1995 Aug; 16(8):1036-43. PubMed ID: 8665964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAF-induced platelet aggregation ex vivo as a method for monitoring pharmacological activity in healthy volunteers.
    Adamus WS; Heuer H; Meade CJ
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):415-20. PubMed ID: 2747341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet aggregation in acute coronary syndromes: use of a new aggregometer with laser light scattering to assess platelet aggregability.
    Eto K; Takeshita S; Ochiai M; Ozaki Y; Sato T; Isshiki T
    Cardiovasc Res; 1998 Oct; 40(1):223-9. PubMed ID: 9876335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
    Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemia.
    Elisaf M; Karabina SA; Bairaktari E; Goudevenos JA; Siamopoulos KC; Tselepis AD
    Platelets; 1999; 10(2-3):124-31. PubMed ID: 16801081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of plasma protein content and platelet number on the potency of PAF and its antagonist RP 59227 in rabbit platelet preparations.
    Floch A; Cavero I
    Br J Pharmacol; 1990 May; 100(1):163-7. PubMed ID: 2372657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
    Apprill P; Schmitz JM; Campbell WB; Tilton G; Ashton J; Raheja S; Buja LM; Willerson JT
    Circulation; 1985 Aug; 72(2):397-405. PubMed ID: 2988822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplasty.
    Goudevenos J; Tselepis AD; Vini MP; Michalis L; Tsoukatos DC; Elisaf M; Ninio E; Sideris DA
    Eur J Clin Invest; 2001 Jan; 31(1):15-23. PubMed ID: 11168434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor (PAF)-induced platelet aggregation. Modulation by plasma adenosine and methylxanthines.
    Agarwal KC; Clarke E; Rounds S; Parks RE; Huzoor-Akbar
    Biochem Pharmacol; 1994 Nov; 48(10):1909-16. PubMed ID: 7986202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generation.
    Macconi D; Viganò G; Bisogno G; Galbusera M; Orisio S; Remuzzi G; Livio M
    Am J Kidney Dis; 1992 Apr; 19(4):318-25. PubMed ID: 1562019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Markers of inflammation and platelet aggregation in patients with non ST elevation acute coronary syndrome treated with atorvastatin or pravastatin].
    Pokrovskaia EV; Vaulin NA; Gratsianskiĭ NA; Averkov OV; Deev AD
    Kardiologiia; 2003; 43(1):7-18. PubMed ID: 12891281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets.
    Nunez D; Kumar R; Hanahan DJ
    Arch Biochem Biophys; 1989 Aug; 272(2):466-75. PubMed ID: 2502069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin.
    Lecrubier C; Conard J; Horellou MH; Samama M
    Agents Actions; 1983 Feb; 13(1):77-80. PubMed ID: 6858789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo.
    Yue TL; Rabinovici R; Farhat M; Feuerstein G
    J Lipid Mediat; 1991; 3(1):13-26. PubMed ID: 1768837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.
    Montrucchio G; Alloatti G; Mariano F; Lupia E; Lucchina PG; Musso E; Emanuelli G; Camussi G
    Circ Res; 1993 Mar; 72(3):658-70. PubMed ID: 8381725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pA2 values for antagonists of platelet activating factor on aggregation of rabbit platelets.
    O'Donnell SR; Barnett CJ
    Br J Pharmacol; 1988 Jun; 94(2):437-42. PubMed ID: 3293683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antiplatelet agents on platelet aggregation induced by platelet--activating factor (PAF) in human whole blood.
    Chan WP; Levy JV
    Prostaglandins; 1991 Oct; 42(4):337-42. PubMed ID: 1665568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.